Lonza
Eric Blomgren is an experienced business development professional with a strong background in the pharmaceutical and biopharmaceutical industries. Currently serving as Director of Business Development at Lonza since April 2017, Eric specializes in small molecule design, development, and manufacturing, with expertise in HPAPI, milling/micronization, and innovative dosage forms. Previous roles include business development positions at Eurofins Bioanalytical Services and Xcelience, where Eric focused on biotherapeutic bioanalysis and clinical trial manufacturing solutions, respectively. Eric's prior experience also encompasses sales leadership at Avantor Performance Materials, Metrics, Inc., EMD Chemicals, and ISC BioExpress, highlighting a consistent track record in enhancing sales strategies and market presence. Eric holds a BA in Environmental Science from the University of Massachusetts Lowell.
This person is not in the org chart
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.